CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
Lund, Sweden, May 14, 2024 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announced it has entered into an exclusive distribution agreement with MTEC Company (“MTEC”) to market and sell the CLS TRANBERG® product portfolio in France.Since December 2023 the TRANBERG system is being used in the French national study IRMPROFT . Based on the growing interest for focal therapies in France, CLS is now entering into an exclusive distribution agreement with MTEC, a national French company with long history and experience